Erythropoietin (EPO), a kidney cytokine regulating hematopoiesis, is also produced in the brain after oxidative/nitrosative stress. Hypoxia inducible transcription factor-1 (HIF-1) upregulates EPO following hypoxic stimuli. Here we propose to study preconditioning with EPO to show that it protects neurons in models of ischemic and degenerative damage due to excitotoxins and consequent generation of free radicals, including nitric oxide (NO). We propose to show that activation of neuronal EPO receptors (EPO-Rs) prevents N-methyl-D aspartate (NMDA)- and NO-induced apoptosis by triggering cross talk between the Janus kinase-2 (Jak2) and nuclear factor KB (NF-KB) signaling pathways. EPO-R - mediated activation of Jak2 leads to phosphorylation of the inhibitor of NF-KB (IKB), subsequent nuclear translocation of the transcription factor NF-KB, and NF-KB-dependent transcription of neuroprotective genes. Transfection of cerebrocortical neurons with a dominant -interfering form of Jak2 or an IKB superrepressor blocks EPO-mediated prevention of neuronal apoptosis. Thus neuronal EPO-Rs activate a neuroprotective pathway that is distinct from previously well characterized Jak and NF-KB functions. Moreover, this EPO effect may underlie neuroprotection mediated by hypoxic-ischemic preconditioning. To test this postulate, we will examine the neuroprotective properties of EPO-related molecules in a mouse middle cerebral artery occlusion model of stroke using the intraluminal suture method.
The Specific Aims are as follows: To characterize EPO- induced activation of the NF-KB pathway in neuroprotection. 2. To test whether NF-KB activation following EPO exposure in mixed neuronal-glial cerebrocortical cultures occurs primarily in neurons. 3. To investigate the possibility of a direct role of EPO-activated Jak2 in NF-KB signaling. 4. To study the treatment of stroke in a mouse model with EPO-related molecules. As a proof-of principle of the involvement f o EPO signaling, we will also test these drugs as well as the effect of increased endogenous EPO in transgenic mice expressing a truncated WPO-R that is hypersensitive to EPO-induced Jak2 signaling compared to the normal full-length receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS043242-03
Application #
6764158
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Jacobs, Tom P
Project Start
2002-07-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
3
Fiscal Year
2004
Total Cost
$376,200
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kang, Yeon-Joo; Digicaylioglu, Murat; Russo, Rossella et al. (2010) Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders. Ann Neurol 68:342-52
Nakagomi, Saya; Barsoum, Mark J; Bossy-Wetzel, Ella et al. (2008) A Golgi fragmentation pathway in neurodegeneration. Neurobiol Dis 29:221-31
Satoh, Takumi; Kosaka, Kunio; Itoh, Ken et al. (2008) Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem 104:1116-31
Satoh, Takumi; Lipton, Stuart A (2007) Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci 30:37-45
Barsoum, Mark J; Yuan, Hua; Gerencser, Akos A et al. (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25:3900-11
Satoh, T; Okamoto, S-i; Cui, J et al. (2006) Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc Natl Acad Sci U S A 103:768-73
Kaul, M; Lipton, S A (2005) Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin. Neurotox Res 8:167-86
Manabe, Shin-Ichi; Gu, Zezong; Lipton, Stuart A (2005) Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 46:4747-53
Helton, Rob; Cui, Jiankun; Scheel, John R et al. (2005) Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 25:4099-107
Bossy-Wetzel, Ella; Schwarzenbacher, Robert; Lipton, Stuart A (2004) Molecular pathways to neurodegeneration. Nat Med 10 Suppl:S2-9

Showing the most recent 10 out of 11 publications